- Report
- February 2026
- 396 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- February 2026
- 467 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- February 2026
- 392 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- February 2026
- 384 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- February 2026
- 192 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- February 2026
- 485 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- February 2026
- 274 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- February 2026
- 402 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- February 2026
- 366 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- February 2026
- 407 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- February 2026
- 235 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- February 2026
- 375 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- February 2026
- 492 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- February 2026
- 286 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- February 2026
- 383 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- February 2026
- 282 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- February 2026
- 372 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- February 2026
- 204 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- February 2026
- 274 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- February 2026
- 384 Pages
Global
From €5120EUR$5,850USD£4,451GBP

Retinopathy is a medical condition that affects the retina, the light-sensitive tissue at the back of the eye. It is a leading cause of blindness and visual impairment worldwide. Optical treatments for retinopathy include laser photocoagulation, intravitreal injections, and vitrectomy. Laser photocoagulation is used to reduce the risk of vision loss by sealing off leaking blood vessels in the retina. Intravitreal injections are used to deliver medications directly to the retina to reduce swelling and inflammation. Vitrectomy is a surgical procedure used to remove scar tissue and other debris from the vitreous cavity.
Companies in the retinopathy market include Alcon, Allergan, Bausch + Lomb, Carl Zeiss Meditec, Ellex, Heidelberg Engineering, Nidek, Optos, Topcon, and Zeiss. Show Less Read more